"Salivary LINC00657 and MiRNA-106a As Diagnostic Biomarkers for Oral Squamous Cell Carcinoma, an Observational Diagnostic Study"

Overview

Journal BMC Oral Health

Publisher Biomed Central

Specialty Dentistry

Date 2023 Dec 13

PMID 38087258

Authors

Nayroz Abdel Fattah Tarrad

Sandy Hassan

Olfat Gamil Shaker

Maha Abdelkawy

Affiliations

Soon will be listed here.

Abstract

Background: Early detection and diagnosis of malignant tumors is critical for improving the survival rate and treatment outcomes of oral cancer. Thus, the current prospective investigation was designed to verify the role, sensitivity, and specificity of salivary LINC00657 and miRNA-106a as diagnostic markers in oral squamous cell carcinoma patients as compared to oral lichen planus (as an example of oral potentially malignant disorders) and normal individuals, and to show LINC00657 relation to miR-106a.

Methods: A total of 36 participants were included, subdivided into 3 groups: Group I: 12 patients diagnosed with oral squamous cell carcinoma (OSCC). Group II: 12 patients diagnosed with oral lichen planus (OLP). Group III: 12 systemically free individuals with no oral mucosal lesions. Unstimulated salivary samples were collected from all participants to evaluate level of LINC00657 and miR-106a in different groups using quantitative real-time PCR.

Results: OSCC showed the highest LINC00657 and lowest miR-106a fold change among included groups. Receiver Operating Characteristic (ROC) curve analysis of the two biomarkers for detecting OSCC revealed that LINC00657 had higher diagnostic accuracy (DA) (83.3%) compared to miR-106a (80.4%). As for detecting OLP, ROC analysis showed that miR-106a had higher (DA) (61%) compared to LINC00657 (52.5%). To discriminate OSCC from OLP, the diagnostic accuracy of both markers is the same (75%). Moreover, differentiating OSCC grades II and III, ROC analysis showed that miR-106a had lower (DA) (60%) compared to LINC00657 (DA) (83.3%).

Conclusions: Salivary LINC00657 and miR-106a could be promising diagnostic markers for oral squamous cell carcinoma. Salivary LINC00657 may differentiate oral squamous cell carcinoma from oral potentially malignant disorders with considerable diagnostic accuracy. Moreover, low levels of salivary miR-106a could have the potential to indicate malignancy.

Trial Registration: The study was retrospectively registered on clinicaltrial.gov with NCT05821179 (first trial registration in 26/3/2023), date of registration: 19/4/2023.

Citing Articles

The Global Trends and Advances in Oral Microbiome Research on Oral Squamous Cell Carcinoma: A Systematic Review.

Dumitrescu R, Bolchis V, Fratila A, Jumanca D, Buzatu B, Sava-Rosianu R Microorganisms. 2025; 13(2).

PMID: 40005740 PMC: 11858510. DOI: 10.3390/microorganisms13020373.

Salivary miRNAs and cytokines associated with diagnosis and prognosis of oral squamous cell carcinoma.

Qin Y, Dong X, Li B Front Cell Dev Biol. 2025; 13:1531016.

PMID: 39911325 PMC: 11794800. DOI: 10.3389/fcell.2025.1531016.

Leveraging Saliva for Insights into Head and Neck Cancer.

Rashid S, Puttagunta P, Pamulapati S, Yang J, Pocha S, Saba N Int J Mol Sci. 2025; 25(24.

PMID: 39769275 PMC: 11678725. DOI: 10.3390/ijms252413514.

A new perspective on diagnostic strategies concerning the potential of saliva-based miRNA signatures in oral cancer.

Prasad M, Sekar R, Priya M, Varma S, Karobari M Diagn Pathol. 2024; 19(1):147.

PMID: 39548527 PMC: 11568613. DOI: 10.1186/s13000-024-01575-1.

ST8SIA6-AS1, a novel lncRNA star in liver cancer.

Qiu C, Fan H, Tao S, Deng Z, Luo H, Liu F Front Cell Dev Biol. 2024; 12:1435664.

PMID: 39211393 PMC: 11358109. DOI: 10.3389/fcell.2024.1435664.

References

Omar E . Current concepts and future of noninvasive procedures for diagnosing oral squamous cell carcinoma--a systematic review. Head Face Med. 2015; 11:6. PMC: 4396078. DOI: 10.1186/s13005-015-0063-z. View

Wang M, Jiang S, Yu F, Zhou L, Wang K . Noncoding RNAs as Molecular Targets of Resveratrol Underlying Its Anticancer Effects. J Agric Food Chem. 2019; 67(17):4709-4719. DOI: 10.1021/acs.jafc.9b01667. View

Ghafouri-Fard S, Azimi T, Hussen B, Abak A, Taheri M, Dilmaghani N . Non-coding RNA Activated by DNA Damage: Review of Its Roles in the Carcinogenesis. Front Cell Dev Biol. 2021; 9:714787. PMC: 8415109. DOI: 10.3389/fcell.2021.714787. View

Li Z, Lei H, Luo M, Wang Y, Dong L, Ma Y . DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. Gastric Cancer. 2014; 18(1):43-54. DOI: 10.1007/s10120-014-0340-8. View

Bi S, Wang Y, Feng H, Li Q . Long noncoding RNA LINC00657 enhances the malignancy of pancreatic ductal adenocarcinoma by acting as a competing endogenous RNA on microRNA-433 to increase PAK4 expression. Cell Cycle. 2020; 19(7):801-816. PMC: 7145330. DOI: 10.1080/15384101.2020.1731645. View

Thompson-Harvey A, Yetukuri M, Hansen A, Simpson M, Adjei Boakye E, Varvares M . Rising incidence of late-stage head and neck cancer in the United States. Cancer. 2019; 126(5):1090-1101. DOI: 10.1002/cncr.32583. View

Tandon P, Dadhich A, Saluja H, Bawane S, Sachdeva S . The prevalence of squamous cell carcinoma in different sites of oral cavity at our Rural Health Care Centre in Loni, Maharashtra - a retrospective 10-year study. Contemp Oncol (Pozn). 2017; 21(2):178-183. PMC: 5611509. DOI: 10.5114/wo.2017.68628. View

Zhou K, Ou Q, Wang G, Zhang W, Hao Y, Li W . High long non-coding RNA NORAD expression predicts poor prognosis and promotes breast cancer progression by regulating TGF-β pathway. Cancer Cell Int. 2019; 19:63. PMC: 6425604. DOI: 10.1186/s12935-019-0781-6. View

Carrozzo M, Thorpe R . Oral lichen planus: a review. Minerva Stomatol. 2009; 58(10):519-37. View

10.

Halazonetis T, Gorgoulis V, Bartek J . An oncogene-induced DNA damage model for cancer development. Science. 2008; 319(5868):1352-5. DOI: 10.1126/science.1140735. View

11.

Shaker O, Ali M, Ahmed T, Zaki O, Ali D, Hassan E . Association between LINC00657 and miR-106a serum expression levels and susceptibility to colorectal cancer, adenomatous polyposis, and ulcerative colitis in Egyptian population. IUBMB Life. 2019; 71(9):1322-1335. DOI: 10.1002/iub.2039. View

12.

Minhas S, Sajjad A, Kashif M, Taj F, Waddani H, Khurshid Z . Oral Ulcers Presentation in Systemic Diseases: An Update. Open Access Maced J Med Sci. 2020; 7(19):3341-3347. PMC: 6953949. DOI: 10.3889/oamjms.2019.689. View

13.

Pan Y, Wei L, Wu X, Huo F, Mou J, Pei D . MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5. Cell Death Dis. 2017; 8(10):e3155. PMC: 5680926. DOI: 10.1038/cddis.2017.561. View

14.

Guruaribam V, Sarumathi T . Relevance of serum and salivary sialic acid in oral cancer diagnostics. J Cancer Res Ther. 2020; 16(3):401-404. DOI: 10.4103/jcrt.JCRT_512_19. View

15.

Lee R, Ambros V . An extensive class of small RNAs in Caenorhabditis elegans. Science. 2001; 294(5543):862-4. DOI: 10.1126/science.1065329. View

16.

Yu S, Peng H, Zhu Q, Wu Y, Wu F, Han C . Silencing the long noncoding RNA NORAD inhibits gastric cancer cell proliferation and invasion by the RhoA/ROCK1 pathway. Eur Rev Med Pharmacol Sci. 2019; 23(9):3760-3770. DOI: 10.26355/eurrev_201905_17802. View

17.

Warnakulasuriya S . Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2008; 45(4-5):309-16. DOI: 10.1016/j.oraloncology.2008.06.002. View

18.

Hu B, Cai H, Zheng R, Yang S, Zhou Z, Tu J . Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression. Int J Biochem Cell Biol. 2017; 92:34-42. DOI: 10.1016/j.biocel.2017.09.008. View

19.

Xie Z, Zhou F, Yang Y, Li L, Lei Y, Lin X . Lnc-PCDH9-13:1 Is a Hypersensitive and Specific Biomarker for Early Hepatocellular Carcinoma. EBioMedicine. 2018; 33:57-67. PMC: 6085584. DOI: 10.1016/j.ebiom.2018.06.026. View

20.

Huang Q, Xing S, Peng A, Yu Z . NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis. Biosci Rep. 2020; 40(1). PMC: 6981097. DOI: 10.1042/BSR20193489. View